Sophie Mader and Ville Kaila, Technical University of Munich (IMAGE)
Caption
A research team from the Technical University of Munich (TUM) has now for the first time deciphered the molecular mechanism of the enzyme AsqJ. Their findings might open up new options in the production of pharmaceutically active molecules. The image shows Sophie Mader and Prof. Ville Kaila looking at simulations of the two AsqJ variants.
Credit
Andreas Battenberg/TUM
Usage Restrictions
None
License
Licensed content